Main Session
Sep
28
PQA 04 - Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2464 - Inactivation of Interferon Signaling Mediates Resistance to CAR T Cell Therapy through Establishment of an Immunosuppressive Tumor Niche and Is Overcome by Unconjugated ISG15
Presenter(s)
Sharareh Gholamin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA